Melanoma 2024: 34rd Annual Cutaneous Malignancy Update

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.

URL:
Tickets: https://go.evvnt.com/1408643-0?pid=10018

Prices:
In-Person Physicians (MD, DO, MBBS): USD 425.00,
In-Person RN, NP, PA, Others: USD 325.00,
In-Person Students, Residents, Fellows: USD 150.00,
Virtual Physicians (MD, DO, MBBS): USD 450.00,
Virtual RN, NP, PA, Others: USD 350.00,
Virtual Students, Residents, Fellows: USD 175.00

Speakers: Surget Cox, MD, Michael Davis, MD, Frederick Fish, MD, Lisa Fronek, DO, Brendan Gaylis, MD, Hugh Greenway, MD, Gregory Hosler, MD, Cora Humberson, MD, Aleksandr Itkin, MD, Benjamin Kelley, MD, David Kent, MD, Geva Mannor, MD, Beth Palla, MD, James Patterson, MD, Caroline Piggott, MD, Merrick Ross, MD, Elina Shustef, DO, Laura Taylor, MD, Prabhakar Tripuraneni, MD